Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-02-24

Clinical Trial Update: Efficacy and Safety of Leningrado 5 Association in the Treatment of Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Leningrado 5 Association for hypertension was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leningrado 5 Association

Snippet

Sponsor: EMS | Conditions: Arterial Hypertension | Phase 3 | Status: WITHDRAWN